Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

EVAX Evaxion Biotech A/S

Market Closed 12-20 16:00:00 EST

0.9200

+0.0299

+3.36%

盘后0.8967

-0.0233-2.53%

18:17 EST

High0.9600	Low0.8836	Vol73.49K
Open0.8900	D1 Closing0.8901	Amplitude8.58%
Mkt Cap5.40M	Tradable Cap3.25M	Total Shares5.87M
T/O66.51K	T/O Rate2.08%	Tradable Shares3.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"EVAX","market":"US","secType":"STK","nameCN":"Evaxion Biotech A/S","latestPrice":0.92,"timestamp":1734728400000,"preClose":0.8901,"halted":0,"volume":73490,"hourTrading":{"tag":"盘后","latestPrice":0.8967,"preClose":0.92,"latestTime":"18:17 EST","volume":196,"amount":176.3672,"timestamp":1734736666099},"delay":0,"floatShares":3531886,"shares":5866055,"eps":-3.782341,"marketStatus":"Market Closed","change":0.0299,"latestTime":"12-20 16:00:00 EST","open":0.89,"high":0.96,"low":0.883631,"amount":66510.217434,"amplitude":0.085798,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.782341,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1734944400000},"marketStatusCode":7,"adr":0,"adrRate":10,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":0.8901,"preHourTrading":{"tag":"盘前","latestPrice":0.9012,"preClose":0.8901,"latestTime":"08:39 EST","volume":28,"amount":25.2336,"timestamp":1734701949164},"postHourTrading":{"tag":"盘后","latestPrice":0.8967,"preClose":0.92,"latestTime":"18:17 EST","volume":196,"amount":176.3672,"timestamp":1734736666099},"volumeRatio":0.6370448195497201,"impliedVol":2.1042,"impliedVolPercentile":0.28},"requestUrl":"/m/hq/s/EVAX","defaultTab":"news","newsList":[{"id":"2492133357","title":"European Equities Traded in the US as American Depositary Rise in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2492133357","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492133357?lang=en_us&edition=fundamental","pubTime":"2024-12-19 00:12","pubTimestamp":1734538373,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were trending higher late Wednesday morning, rising 0.18% to 1,338.75 on the S&P Europe Select ADR Index.From continental Europe, the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","SAN.AU","BK4521","LU2236285917.USD","BK4585","LU1829250122.USD","VOD","BK4132","SNY","MREO","BK4505","DBVT","BK4007","BCYC","IE00BFXG1179.USD","PHG","LU0889565916.HKD","BK4207","AFG","LU0320765992.SGD","LU2456880835.USD","BK4082","LU2417539215.USD","LU0109394709.USD","TRIB","GNFT","BK4532","LU2462157665.USD","TCBP","AUTL","BK4568","AZN","BK4117","BK7142","SAN","BBVA","EVAX","EDAP","BK4107","BK4588"],"gpt_icon":0},{"id":"2492950299","title":"BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492950299","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492950299?lang=en_us&edition=fundamental","pubTime":"2024-12-17 22:07","pubTimestamp":1734444424,"startTime":"0","endTime":"0","summary":"BRIEF-Evaxion Pursues Agreement With EIB To Bolster Equity Through Conversion Of Debt Into EquityDec 17 (Reuters) - Evaxion Biotech A/S EVAX.O:EVAXION PURSUES AGREEMENT WITH EIB TO BOLSTER EQUITY THRO","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2492508019","title":"Evaxion Biotech to Convert Debt to Equity in Strategic Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2492508019","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492508019?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:47","pubTimestamp":1734443261,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Evaxion Biotech ( ($EVAX) ). Evaxion Biotech is in advanced discussions with the European Investment Bank (EIB)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-to-convert-debt-to-equity-in-strategic-move?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-to-convert-debt-to-equity-in-strategic-move?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","EQR","BK4139","EVAX","BK4215","BK4585"],"gpt_icon":0},{"id":"2492954064","title":"Evaxion Biotech pursues agreement with EIB to bolster equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492954064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492954064?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:16","pubTimestamp":1734441373,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) is pursuing a significant expected enhancement of its equity and capital structure through a conversion of debt into equity....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-pursues-agreement-with-eib-to-bolster-equity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-pursues-agreement-with-eib-to-bolster-equity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2492543639","title":"Evaxion Biotech a/S - in Advanced Discussions With Eib for €3.5 Million Loan Conversion","url":"https://stock-news.laohu8.com/highlight/detail?id=2492543639","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492543639?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","EVAX"],"gpt_icon":0},{"id":"2492395438","title":"Evaxion Pursues Agreement With Eib to Bolster Equity Through Conversion of Debt Into Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492395438","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492395438?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUACB7VYH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2492895461","title":"Evaxion pursues agreement with EIB to bolster equity through conversion of debt into equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2492895461","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492895461?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440400,"startTime":"0","endTime":"0","summary":"Evaxion and the European Investment Bank  are in advanced discussions about conversion of 3.5 million out of Evaxion’s 7 million loan with EIB into an equity-type instrument. Such conversion is expected to increase Evaxion’s equity by $3.7 million immediately upon completion. The conversion would significantly enhance Evaxion’s equity and capital structure. As such, it is an important part of Evaxion’s plan on ensuring ongoing compliance with the Nasdaq listing requirements. About EVAXION Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-Immunology. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral disea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uytrwEfXgkMDzYGWWPzG2g--~B/aD04MTc7dz00NzI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c9e7552492c4f1a24fb1488cbbdf90ad","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uytrwEfXgkMDzYGWWPzG2g--~B/aD04MTc7dz00NzI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c9e7552492c4f1a24fb1488cbbdf90ad"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/evaxion-pursues-agreement-eib-bolster-130000684.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","WRD","EVAX","PHH"],"gpt_icon":0},{"id":"2492994616","title":"European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2492994616","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492994616?lang=en_us&edition=fundamental","pubTime":"2024-12-17 00:10","pubTimestamp":1734365429,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week off higher late Monday morning, rising 0.32% to 1,343.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and Grifols , which rose 4.3% and 3.9% respectively. They were followed by medical device maker EDAP TMS  and pharmaceutical company Ascendis Pharma , which increased 3.1% and 2.7% respectively.The decliners from continental Europe were led by biotech firm Evaxion Biotech  and biopharmaceutical company DBV Technologies , which fell 18% and 3.1% respectively. They were followed by biopharmaceutical company Cellectis  and petroleum refiner Equinor , which were down 2.8% and 2.4% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics  and biotech firm Autolus Therapeutics , which advanced 8.6% and 5% respectively. They were followed by biopharmaceutical companies Verona Pharma  a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1829250122.USD","LU0320765646.SGD","EDAP","ARGX","BK4588","LU0320765992.SGD","AFG","EQNR","LU0072461881.USD","VRNA","BCYC","BK4107","BK4139","BK4162","PUK","ASND","LU0109394709.USD","MREO","BK4007","BK4201","BK4117","BK4505","BK4082","AMRN","EVAX","BK4585","LU0162691827.USD","LU1162221912.USD","TRIB","AUTL","LU0889565916.HKD","BP","GRFS","CLLS","DBVT"],"gpt_icon":0},{"id":"2491918372","title":"European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, Down 1.5% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2491918372","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491918372?lang=en_us&edition=fundamental","pubTime":"2024-12-14 00:10","pubTimestamp":1734106214,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.25% to 1,337.43 on the S&P Europe Select ADR Index, which is down 1.5% for the week.From ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TCBP","NCNA","BK4554","SAN.AU","NTZ","BK7141","BK4023","BK4139","BK4521","BK4515","DBVT","ING.AU","BDRX","AKTX","BK4020","BK4107","AFG","BK4591","SAN","EVAX","MTLS","BK4095","BK4546","ING","ERIC","BK7505","BK4207","DEO","BK4117","BK4169","VRNA","ADAP","BBVA","BCYC","BK4588","BK7142","BK4007","DGE.UK","BK4585"],"gpt_icon":1},{"id":"2490938590","title":"Evaxion Biotech Advances AI-Driven Precision Cancer Vaccine Concept","url":"https://stock-news.laohu8.com/highlight/detail?id=2490938590","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490938590?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:27","pubTimestamp":1734010030,"startTime":"0","endTime":"0","summary":"Evaxion Biotech ( ($EVAX) ) just unveiled an update. Evaxion Biotech has announced a significant advancement in its precision cancer vaccine concep...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-advances-ai-driven-precision-cancer-vaccine-concept?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-advances-ai-driven-precision-cancer-vaccine-concept?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2490383656","title":"Evaxion Biotech establishes new Ai-derived precision cancer vaccine concept","url":"https://stock-news.laohu8.com/highlight/detail?id=2490383656","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490383656?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:11","pubTimestamp":1734009065,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) obtains preclinical Proof-of-Concept, PoC, for its precision cancer vaccine concept targeting non-conventional ERV tumor ant...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-establishes-new-ai-derived-precision-cancer-vaccine-concept?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/evaxion-biotech-establishes-new-ai-derived-precision-cancer-vaccine-concept?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PACI.U","BK4139","EVAX"],"gpt_icon":0},{"id":"2490238821","title":"Evaxion establishes new AI-derived precision cancer vaccine concept","url":"https://stock-news.laohu8.com/highlight/detail?id=2490238821","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490238821?lang=en_us&edition=fundamental","pubTime":"2024-12-12 21:00","pubTimestamp":1734008400,"startTime":"0","endTime":"0","summary":"Evaxion’s AI-Immunology platform allows for the design of precision cancer vaccines targeting non-conventional ERV tumor antigens shared across patientsNovel preclinical data confirms the effectivenes","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/12/2996150/0/en/Evaxion-establishes-new-AI-derived-precision-cancer-vaccine-concept.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVAX","BK4139","PHH","WRD"],"gpt_icon":0},{"id":"2490010141","title":"European Equities Traded in the US as American Depositary Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2490010141","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490010141?lang=en_us&edition=fundamental","pubTime":"2024-12-11 00:07","pubTimestamp":1733846871,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Tuesday morning, declining 0.38% to 1,348.76 on the S&P Europe Select ADR Index.From continental Europe, the gainers ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0320765646.SGD","BK4142","AFG","HSBA.UK","BCYC","LU0648005311.SGD","LU2236285917.USD","CUK","BK4117","SAN","03143","DBVT","VEON","EDAP","BK4521","LU0823431647.USD","HSHD.SI","00005","TRVG","DAVA","LU0162691827.USD","AKTX","BK4585","BK4077","SLN","OPRA","HSBC","LU0417516738.SGD","LU0072461881.USD","BK4107","DAVA.AU","BK7142","LU0348735423.USD","LU0164880469.USD","BK4207","BP","BK4134","BK4082","SAN.AU","BK4007","EVAX","CLLS","LU0149721374.USD","LU1829250122.USD","BK1231","TRIB","BK4139","LU1162221912.USD","BK4023","BK4132"],"gpt_icon":0},{"id":"2490249267","title":"Evaxion announces 2025 milestones reflecting continued strong strategy execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2490249267","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490249267?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:00","pubTimestamp":1733749200,"startTime":"0","endTime":"0","summary":"With most of Evaxion’s strategic milestones for 2024 now successfully achieved, the company announces milestones for 2025. The 2025 key milestones reflect all parts of Evaxion’s strategy for value realization. Evaxion expects to discuss the milestones at an investor event in the first quarter of 2025. COPENHAGEN, Denmark, December 9, 2024 - Evaxion Biotech A/S  , a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, announces its strategic milestones for 2025 after having now achieved almost all the milestones set for 2024.The 2025 milestones reflect Evaxion’s high activity level, broad pipeline and strong external interest in potential partnerships around both our AI-Immunology platform and pipeline assets. As such, the milestones underscore our continued anticipated strategic progress.All this is reflected in the 2025 milestones as listed below. Evaxion expects to discuss the milestones at an investor event in the first quarter of 2025.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/uytrwEfXgkMDzYGWWPzG2g--~B/aD04MTc7dz00NzI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c9e7552492c4f1a24fb1488cbbdf90ad","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/uytrwEfXgkMDzYGWWPzG2g--~B/aD04MTc7dz00NzI1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c9e7552492c4f1a24fb1488cbbdf90ad"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/evaxion-announces-2025-milestones-reflecting-130000534.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EVAX","WRD","PHH","BK4139"],"gpt_icon":0},{"id":"2489598116","title":"European Equities Traded in the US as American Depositary Receipts Slightly Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2489598116","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489598116?lang=en_us&edition=fundamental","pubTime":"2024-12-05 00:12","pubTimestamp":1733328763,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly higher late Wednesday morning, rising 0.15% to 1,345.27 on the S&P Europe Select ADR Index.From continental Europe, the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4117","BK4588","BK4023","BK4082","DAVA","BDRX","EVAX","LU0084288595.USD","BK4134","BK4142","AUTL","ARGX","NTZ","BK4009","BK4139","BK4107","BK4585","TCBP","TRIB","DAVA.AU","BK4528","TRVG","LU0648005311.SGD","BK4505","ADAP","BK4095","CUK","LU0109394709.USD","LU0320765992.SGD","SAP","DBVT","SQNS","AFG","SLN","IE00BFMHRM44.USD","CRTO","BK4141","BK4077","LU0889565916.HKD"],"gpt_icon":0},{"id":"2488103913","title":"Evaxion Biotech Unveils Precision Cancer Vaccine Breakthrough","url":"https://stock-news.laohu8.com/highlight/detail?id=2488103913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488103913?lang=en_us&edition=fundamental","pubTime":"2024-12-03 19:28","pubTimestamp":1733225302,"startTime":"0","endTime":"0","summary":"Evaxion Biotech (EVAX) has released an update. Evaxion Biotech is set to showcase its pioneering preclinical proof-of-concept for a precision cance...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-unveils-precision-cancer-vaccine-breakthrough?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/evaxion-biotech-unveils-precision-cancer-vaccine-breakthrough?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2488603261","title":"European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2488603261","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488603261?lang=en_us&edition=fundamental","pubTime":"2024-12-03 00:16","pubTimestamp":1733156163,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts kicked off the week trending lower late Monday morning, declining 0.37% to 1,326.63 on the S&P Europe Select ADR Index.From continent","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TCBP","LU1093756325.SGD","BP","BK4554","LU2129689431.USD","IE00BZ1G4Q59.USD","LU2237443382.USD","NTZ","BK4023","BK4139","BK4561","BK4515","LU1829250122.USD","BK7104","LU0320765646.SGD","LU0162691827.USD","AKTX","LU0072461881.USD","MREO","BK4107","AFG","BK4591","GNFT","TRIB","BK4599","BK4141","LU1093756168.USD","EVAX","BK4095","NVO.AU","BK4201","NVO","ERIC","LU2237443978.SGD","BK4505","LU2237443895.HKD","LU2237443465.HKD","SLN","VRNA","TTE","BK4588","SQNS","BK4082","LU2237443622.USD","BK4007","LU2129689514.USD","LU0154236417.USD","BK4142","CUK","OPRA"],"gpt_icon":1},{"id":"2488917676","title":"Evaxion to present preclinical Proof-of-Concept for precision ERV cancer vaccine concept at ESMO Immuno-Oncology Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2488917676","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488917676?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:00","pubTimestamp":1733144400,"startTime":"0","endTime":"0","summary":"COPENHAGEN, Denmark, December 2, 2024 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology powered vaccines, will present preclin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/02/2989753/0/en/Evaxion-to-present-preclinical-Proof-of-Concept-for-precision-ERV-cancer-vaccine-concept-at-ESMO-Immuno-Oncology-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PACI.U","BK4139","WRD","EVAX"],"gpt_icon":0},{"id":"2484596591","title":"Evaxion Biotech files for offering of ADSs","url":"https://stock-news.laohu8.com/highlight/detail?id=2484596591","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484596591?lang=en_us&edition=fundamental","pubTime":"2024-11-19 06:12","pubTimestamp":1731967929,"startTime":"0","endTime":"0","summary":"Evaxion Biotech A/S (EVAX) files preliminary prospectus offering of up to 5,252,100 American Depositary Shares.\nSEC Filing","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4304561-evaxion-biotech-files-for-offering-of-adss","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["EVAX","BK4139"],"gpt_icon":0},{"id":"2483098803","title":"European Equities Traded in the US as American Depositary Drop in Friday Trading, Down 2.8% for Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2483098803","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483098803?lang=en_us&edition=fundamental","pubTime":"2024-11-16 00:09","pubTimestamp":1731686983,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving lower late Friday morning, declining 0.85% to 1,302.64 on the S&P Europe Select ADR Index, which is down about 2.8% for t","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4548","BK4588","BK4551","PUK","BTI.AU","BDRX","SAN","BNTX","AKTX","BK4075","LYG","BK4117","BK4568","BK4505","BK4107","BK4585","SAN.AU","LU0109394709.USD","ARGX","BBVA","BK4207","LU0889565916.HKD","BK7062","BK4535","BK4162","AFG","BCYC","BK4007","BK4139","ASND","DBVT","LU0320765992.SGD","BK7142","MREO","TCBP","BK4521","BTI","CLLS","EVAX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evaxionbiotech.com","stockEarnings":[{"period":"1week","weight":-0.193},{"period":"1month","weight":-0.3429},{"period":"3month","weight":-0.6923},{"period":"6month","weight":-0.6761},{"period":"1year","weight":-0.8664},{"period":"ytd","weight":-0.8658}],"compareEarnings":[{"period":"1week","weight":-0.0216},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0403},{"period":"6month","weight":0.0857},{"period":"1year","weight":0.2506},{"period":"ytd","weight":0.2437}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.269805},{"month":2,"riseRate":0,"avgChangeRate":-0.053098},{"month":3,"riseRate":0,"avgChangeRate":-0.133841},{"month":4,"riseRate":0.75,"avgChangeRate":0.137684},{"month":5,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":6,"riseRate":0.25,"avgChangeRate":-0.055002},{"month":7,"riseRate":0.25,"avgChangeRate":0.052601},{"month":8,"riseRate":0.5,"avgChangeRate":-0.067943},{"month":9,"riseRate":1,"avgChangeRate":0.154645},{"month":10,"riseRate":0.25,"avgChangeRate":-0.004732},{"month":11,"riseRate":0,"avgChangeRate":-0.303517},{"month":12,"riseRate":0,"avgChangeRate":-0.206217}],"exchange":"NASDAQ","name":"Evaxion Biotech A/S","nameEN":"Evaxion Biotech A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Evaxion Biotech A/S,EVAX,Evaxion Biotech A/S股票,Evaxion Biotech A/S股票老虎,Evaxion Biotech A/S股票老虎国际,Evaxion Biotech A/S行情,Evaxion Biotech A/S股票行情,Evaxion Biotech A/S股价,Evaxion Biotech A/S股市,Evaxion Biotech A/S股票价格,Evaxion Biotech A/S股票交易,Evaxion Biotech A/S股票购买,Evaxion Biotech A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evaxion Biotech A/S(EVAX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Evaxion Biotech A/S(EVAX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction